Celldex Therapeutics Jumps 25% Amid Brain Cancer Study
November 17, 2014 at 10:47 AM EST
Celldex Therapeutics, Inc. (NASDAQ: CLDX) gained sharply Monday on news released late last week a small trial of its brain cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.